Depickere S, Pannus P, Houben S, Charles A, et al. Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial. Vaccine 2026;89:128897.
PMID: 42398210